Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    You have access
    Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
    Ruben Y. Gabriëls, Lisanne E. van Heijst, Wouter T.R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas and Wouter B. Nagengast
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.122.264656
  • Initial Results of <sup>68</sup>Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
    You have access
    Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
    Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871
  • Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
    You have access
    Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
    Robert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang P. Fendler, Phillip H. Kuo and Ken Herrmann
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 731-737; DOI: https://doi.org/10.2967/jnumed.122.264741
  • Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    You have access
    Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    Robert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 738-743; DOI: https://doi.org/10.2967/jnumed.118.215434
  • A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
    You have access
    A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
    Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 744-750; DOI: https://doi.org/10.2967/jnumed.122.264448
  • Myocardial External Efficiency in Asymptomatic Severe Primary Mitral Regurgitation Using <sup>11</sup>C-Acetate PET
    You have access
    Myocardial External Efficiency in Asymptomatic Severe Primary Mitral Regurgitation Using 11C-Acetate PET
    Jens Sorensen, Johannes Bergsten, Tomasz Baron, Lovisa Holm Orndahl, Tanja Kero, Tomas Bjerner, Eva-Maria Hedin, Hendrik J. Harms, Rafael Astudillo and Frank A. Flachskampf
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 645-651; DOI: https://doi.org/10.2967/jnumed.122.264945
  • Response Prediction Using <sup>18</sup>F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    You have access
    Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    Xinying Hu, Tao Zhou, Jiazhong Ren, Jinghao Duan, Hongbo Wu, Xiaoli Liu, Zhengshuai Mu, Ning Liu, Yuchun Wei and Shuanghu Yuan
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 625-631; DOI: https://doi.org/10.2967/jnumed.122.264638
  • Prognostic Value of Tumor Volume Assessment on PSMA PET After <sup>177</sup>Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0
    You have access
    Prognostic Value of Tumor Volume Assessment on PSMA PET After 177Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0
    Felix Kind, Ann-Christin Eder, Cordula A. Jilg, Philipp E. Hartrampf, Philipp T. Meyer, Juri Ruf and Kerstin Michalski
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 605-610; DOI: https://doi.org/10.2967/jnumed.122.264489
  • <sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
    You have access
    18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
    Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, Annouschka Laenen, Paul M. Clement, Karen Geboes, Eric Van Cutsem, Sigrid Stroobants, Chris Verslype, Guy Bormans and Christophe M. Deroose
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 632-638; DOI: https://doi.org/10.2967/jnumed.122.264563
  • You have access
    Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers
    Mahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A. Koerber, Manuel Röhrich, Jürgen Debus, Clemens Kratochwil, Uwe Haberkorn and Frederik L. Giesel
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 618-622; DOI: https://doi.org/10.2967/jnumed.122.264941

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 67
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire